HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody.

Abstract
A 53-year-old-male patient was admitted to the Hiroshima University Hospital in August 2001, with a history of progressive cerebellar ataxia, notable by standing and gait disturbances. Brain computed tomography (CT) and magnetic resonance imaging (MRI) showed no signs of ischemic damage. Two weeks later, left axillary lymphadenopathy developed. The pathological finding was Hodgkin's disease (HD; a classical malignant lymphoma in an early stage). Serum antibodies against Purkinje's cells (anti-Tr antibody) were detected by immunohistochemical study. Thus, we diagnosed this as paraneoplastic cerebellar degeneration (PCD) associated HD. We immediately carried out chemotherapy (ABVD therapy), radiotherapy with 20-30 Gy, steroid pulse and intravenous immunoglobulin (IVIg) without neurologic improvement. The patient was subsequently treated by double filtration plasmapheresis (DFPP), leading to a marked improvement of standing and gait disturbances and to a reduction of autoantibodies, which became undetectable. We conclude that DFPP might be useful in treating patients with cerebellar ataxia, and should be considered as a therapeutic choice for it.
AuthorsYoshihiko Taniguchi, Chie Tanji, Toru Kawai, Hidetoshi Saito, Seiji Marubayashi, Noriaki Yorioka
JournalTherapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (Ther Apher Dial) Vol. 10 Issue 1 Pg. 90-3 (Feb 2006) ISSN: 1744-9979 [Print] Australia
PMID16556143 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantibodies
Topics
  • Autoantibodies (blood)
  • Cerebellar Ataxia (therapy)
  • Hodgkin Disease (complications)
  • Humans
  • Male
  • Middle Aged
  • Paraneoplastic Cerebellar Degeneration (therapy)
  • Plasmapheresis
  • Purkinje Cells (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: